<DOC>
	<DOCNO>NCT00761267</DOCNO>
	<brief_summary>Prospective , open label study ass pharmacokinetics , safety &amp; efficacy anidulafungin use treat child ( age 1 month - &lt; 18 year ) invasive candidiasis , include candidemia ( ICC ) .</brief_summary>
	<brief_title>Study To Assess Pharmacokinetics , Safety &amp; Efficacy Anidulafungin When Treating Children With Invasive Candidiasis</brief_title>
	<detailed_description>Prospective , open label study ass pharmacokinetics , safety &amp; efficacy anidulafungin use treat child ( age 1 month - &lt; 18 year ) invasive candidiasis , include candidemia ( ICC ) . To participate study , time enrollment subject must ( 1 ) either confirm diagnosis ICC mycological evidence highly suggestive Candida sp ( 2 ) infant 1 month &lt; 2 year , high risk candidiasis . All subject meet screen criterion receive IV anidulafungin . Subjects stratify age ( 1 month - &lt; 2 year ; 2 year - &lt; 5 year ; 5 year - &lt; 18 year ) . Subjects may switch oral fluconazole , provide pre-specified criterion meet . Subjects microbiologically confirm ICC must minimum total treatment duration 14 day . The maximum allowed treatment duration anidulafungin 35 day ; maximum total treatment duration study 49 day . At select center , anidulafungin pharmacokinetics assess first 6 subject age 1 month - &lt; 2 year confirm recommend dosage regimen . A population PK-PD analysis perform enrolled subject . Subjects follow safety 6 week FU visit . Efficacy subject confirm ICC assess EOIVT , EOT , 2-week FU 6-week FU visit .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidemia</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Subject must either ( 1 ) high risk candidiasis ( 1 month &lt; 2 year ONLY ) ( 2 ) definitive diagnosis invasive candidiasis/candidemia ( ICC ) ( All age group ) Male female patient 1 month less 18 year age . Any patient allergy drug ; pregnant female lactate . Failed previous antifungal therapy expect live &lt; 3 day . Patients document suspected Candida meningitis .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Anidulafungin</keyword>
	<keyword>pediatrics</keyword>
	<keyword>candidemia</keyword>
	<keyword>invasive candidiasis</keyword>
	<keyword>safety</keyword>
</DOC>